Xencor | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 314.02B 34.8B 2024-12
Alnylam Pharmaceuticals USD 30.35B 4.96B 2024-12
Amgen USD 140.1B 33.03B 2024-12
Arrowhead Research USD 2.34B 69M 2024-12
AstraZeneca GBP 162.31B 17.34B 2024-12
Biogen USD 22.28B 5.95B 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Cytokinetics USD 5.55B 661M 2024-12
GlaxoSmithKline GBP 55.81B 7.05B 2024-12
J&J USD 348.19B 41.93B 2024-12
MacroGenics USD 207M 59M 2024-09
Merck USD 251.65B 36.21B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
Xencor USD 1.61B 203M 2024-12



Xencor Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.